Pravin R. Chaturvedi's most recent trade in Jaguar Health Inc was a trade of 7,304 Warrant to Purchase Common Stock done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 7,304 | 3,600 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 3,785 | 3,785 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2025 | 3,600 | 0 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 3,600 | 3,600 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 3,600 | 3,600 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 39,376 | 39,376 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 4,922 | 4,957 (0%) | 0% | 0 | Common Stock | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 871 | 871 | - | - | Restricted stock units | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 871 | 2,141 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 134 | 1,270 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 134 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 204,192 | 205,328 (1%) | 1% | 0 | Common Stock | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2023 | 44 | 88 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 44 | 44 | - | - | Restricted stock units | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2022 | 31,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 3,333 | 6,666 | - | - | Restricted stock units | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 3,333 | 3,333 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Pravin R. Chaturvedi | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 195,934 | 195,934 | - | - | Restricted stock units |